Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Myocardial Infarction peptide trials
5 selected ClinicalTrials.gov records carrying the official condition label Myocardial Infarction. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
5 selected records.
3 profiles.
2012–2021 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 78 selected PubMed records and 30 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Myocardial Infarction unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT01438086
PeptideScanner retained ClinicalTrials.gov record NCT01438086 at 2026-11-16T17:35:13.282Z. Its registry update date was 2017-03-30, and PeptideScanner's reviewed identity mapping was mecasermin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- March 30, 2017
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00111566
PeptideScanner retained ClinicalTrials.gov record NCT00111566 at 2026-11-15T21:59:29.646Z. Its registry update date was 2013-11-28, and PeptideScanner's reviewed identity mapping was eptifibatide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- November 28, 2013
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00373451
PeptideScanner retained ClinicalTrials.gov record NCT00373451 at 2026-11-15T21:58:19.888Z. Its registry update date was 2012-05-08, and PeptideScanner's reviewed identity mapping was bivalirudin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- May 8, 2012
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Eptifibatide · 2021-05-13
ClinicalTrials.gov record NCT01522417
Completed at the retained observation.
Open attributed record →Bivalirudin · 2017-12-04
ClinicalTrials.gov record NCT00433966
Completed at the retained observation.
Open attributed record →Mecasermin · 2017-03-30
ClinicalTrials.gov record NCT01438086
Completed at the retained observation.
Open attributed record →Eptifibatide · 2013-11-28
ClinicalTrials.gov record NCT00111566
Completed at the retained observation.
Open attributed record →Bivalirudin · 2012-05-08
ClinicalTrials.gov record NCT00373451
Completed at the retained observation.
Open attributed record →